Entry into a Material Definitive Agreement

Business Context and Reporting Period

Company: Aureus Greenway Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 23, 2025
Event Date: July 23, 2025 (Agreements signed); July 25, 2025 (Closing)
Context: The Company announced and closed a private placement of equity securities and a secondary sale of existing shares to raise capital for working capital purposes.

Key Financial Metrics and Transaction Details

  • Gross Proceeds (Private Placement): $26,000,000
  • Net Proceeds: Not specified in the filing text (redacted as "$[--] million").
  • Placement Agent Fees: $2,080,000 (8.0% of gross proceeds) plus $150,000 expense reimbursement.
  • Secondary Sale Proceeds: $8,000,000 total ($4,000,000 for Series A Preferred Stock and $4,000,000 for Common Stock).
  • Securities Issued (Primary Offering):
    • 29,885,057 shares of Common Stock (or Pre-Funded Warrants).
    • 29,885,057 Common Warrants A (Exercise Price: $1.00).
    • 29,885,057 Common Warrants B (Exercise Price: $1.25).
  • Placement Agent Warrants: 2,390,804 warrants issued (Exercise Price: $1.00).
  • Use of Proceeds: Working capital.

Material Changes and Agreements

The filing details the entry into several material definitive agreements on July 23, 2025, which closed on July 25, 2025:

  • Securities Purchase Agreement: Issuance of shares and warrants at a purchase price of $0.87 per unit (share/warrant A/warrant B). Includes a 180-day lock-up on issuing additional equity.
  • Private Stock Purchase Agreement (Secondary Sale): Existing shareholders sold 10,000,000 Series A Preferred Shares ($0.01/share) and 4,000,000 Common Shares ($0.975/share) to new buyers. Proceeds from this portion went to the selling shareholders, not the Company.
  • Registration Rights Agreement: The Company agreed to file a registration statement within 10 days of the agreement and have it effective within 45 days (or 75 days if a full review is required).

Guidance, Risks, and Contingencies

  • Beneficial Ownership Limits: Investors are restricted from exercising warrants or converting pre-funded warrants if it causes their beneficial ownership to exceed 4.99% (or 9.99% at election) of outstanding shares.
  • Warrant Terms: All warrants have a five-year term. Pre-funded warrants have a remaining exercise price of $0.0001 and are immediately exercisable. Common warrants are exercisable on a cashless basis if a registration statement is not effective.
  • Lock-Up Period: The Company is restricted from issuing or announcing the issuance of Common Stock or equivalents for 180 days following the closing, subject to exceptions.
  • Financial Outlook: No specific revenue or earnings guidance was provided in this filing; proceeds are designated for general working capital.

Investor Verification Checklist

  • Verify the exact net proceeds received by the Company, as the filing text redacts this figure.
  • Confirm the effective date of the registration statement for the resale of the newly issued securities.
  • Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and termination provisions.
  • Assess the impact of the 180-day lock-up on the Company's ability to raise additional capital in the near term.
  • Monitor the dilution impact of the 29.8 million shares issued plus the potential exercise of 59.7 million warrants and 2.4 million placement agent warrants.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.